Drug use patterns in COVID-19 patients: A retrospective survey 2021–2022
Article Sidebar
Main Article Content
Abstract
This retrospective survey examines drug use patterns in COVID-19 patients from 2021 to 2022 with 81 participants, who reported 13 symptoms between March and May 2023. Application of the k-means clustering method led to identification of three distinct symptom severities, severe (Cluster I), moderate (Cluster II), and mild (Cluster III), with respective average scores of 3.67±0.87, 3.20±0.98, and 1.87±0.81. In Clusters I and II, myalgia was the most notable symptom, while in Cluster III, sore throat was predominant. On average, individuals in Clusters I–III used 2.00–2.34 types of drugs, with use of a single drug having the highest frequency. Notably, Andrographis paniculata capsules were highly utilized across all clusters (51.85%), while favipiravir was less often used. Furthermore, one in five participants in the combined Clusters I and II employed substantial pharmaceutical interventions for COVID-19 treatment, whereas in Cluster III, this use remained below 10%. This research provides valuable insights into drug use patterns for managing COVID-19. The findings offer crucial information about symptoms from each cluster, tailoring treatment approaches to specific symptom severity clusters as well as overlapping medications.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Akram, A., Qaisrani, K., and Ullah, N. (2021). Frequency of different symptoms in patients with COVID-19. Pakistan Journal of Medical and Health Sciences, 15(11), 3084–3086.
Alves, L. (2021). Brazilian ICUs short of drugs and beds amid COVID-19 surge. The Lancet, 397(10283), 1431–1432.
Alwhaibi, A., Alrwaished, A., Binobydaan, S. M., Alawwad, S., Wajid, S., Bablghaith, S., Alghadeer, S., and Al Arifi, M. N. (2021). Role of pharmacist during COVID-19 pandemic: A retrospective study focused on critically ill COVID-19 patients. Saudi Pharmaceutical Journal, 29(9), 1050–1055.
Bangkok Dusit Medical Services. (2020). Questionnaire for screening for COVID-19. [Online URL: https://investor.Bangkokhospital.com/storage/downloads/shareholders-meeting/agm2020/20200601-bdms-agm2020-enc12-th.pdf] accessed on April 20, 2023. [in Thai]
Çalıca Utku, A., Budak, G., Karabay, O., Güçlü, E., Okan, H. D., and Vatan, A. (2020). Main symptoms in patients presenting in the COVID-19 period. Scottish Medical Journal, 65(4), 127–132.
Ceramella, J., Iacopetta, D., Sinicropi, M. S., Andreu, I., Mariconda, A., Saturnino, C., Giuzio, F., Longo, P., Aquaro, S., and Catalano, A. (2022). Drugs for COVID-19: An update. Molecules, 27(23), 8562.
Chopra, D., Bhandari, B., Sidhu, J. K., Jakhar, K., Jamil, F., and Gupta, R. (2021). Prevalence of self-reported anxiety and self-medication among upper and middle socioeconomic strata amidst COVID-19 pandemic. Journal of Education and Health Promotion, 10, 73.
Conti, V., Sellitto, C., Torsiello, M., Manzo, V., De Bellis, E., Stefanelli, B., Bertini, N., Costantino, M., Maci, C., Raschi, E., Sabbatino, F., Corbi, G., Pagliano, P., and Filippelli, A. (2022). Identification of drug interaction adverse events in patients with COVID-19: A systematic review. JAMA Network Open, 5(4), e227970.
Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16, 297–334.
Dalmaijer, E. S., Nord, C. L., and Astle, D. E. (2022). Statistical power for cluster analysis. BMC Bioinformatics, 23, 205.
Das, K. (2022). Herbal plants as immunity modulators against COVID-19: A primary preventive measure during home quarantine. Journal of Herbal Medicine, 32, 100501.
Fernández-de-Las-Peñas, C., Palacios-Ceña, D., Gómez-Mayordomo, V., Cuadrado, M. L., and Florencio, L. L. (2021). Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): An integrative classification. International Journal of Environmental Research and Public Health, 18(5), 2621.
Hajjar, S. E. (2018). Statistical analysis: Internal-consistency reliability and construct validity. International Journal of Quantitative and Qualitative Research Methods, 6(1), 46–57.
HS.Helpsociety. (2022, May 5). Always ready: Thai wisdom for Thai people. [Image attached]. Facebook. https://www.facebook.com/HS.Helpsociety/photos/a.110237851518801/147706051105314/
HS.Helpsociety. (2023). COVID-19 rescue supporter [Facebook page]. Facebook. Retrieved April 20, 2023, from https://www.facebook.com/HS.Helpsociety
Jamovi. (2022). Jamovi (Version 2.3.18) [Computer Software]. Retrieved from [Online URL: https://www.jamovi.org] accessed on October 2, 2023.
Jayathavaj, V. (2023). Clustering provinces in Thailand based on demographic and COVID-19 epidemiological factors. Science and Technology to Community, 1(1),1–18.
Jayathavaj, V., Judprakob, C., and Yeemee, B. (2022). Analysis of Drug Properties from Female Medicinal formula using cluster analysis: A case study of Moh Krajang Yeemee. Journal of Health Science Nakhon Ratchasima College, 1(1), 40–53.
Jindahra, P., Wongboonsin, K., and Wongboonsin, P. (2022). Demographic and initial outbreak patterns of COVID-19 in Thailand. Journal of Population Research, 39, 567–588.
Kazemioula, G., Golestani, S., Alavi, S. M. A., Taheri, F., Gheshlagh, R. G., and Lotfalizadeh, M. H. (2022). Prevalence of self-medication during COVID-19 pandemic: A systematic review and meta-analysis. Frontiers in Public Health, 10, 1041695.
Kenny, G., McCann, K., O'Brien, C., Savinelli, S., Tinago, W., Yousif, O., Lambert, J. S., O'Broin, C., Feeney, E. R., De Barra, E., Doran, P., Mallon, P. W. G., and All-Ireland Infectious Diseases (AIID) Cohort Study Group. (2022). Identification of distinct long COVID clinical phenotypes through cluster analysis of self-reported symptoms. Open Forum Infectious Diseases, 9(4), ofac060.
Kumar, D., and Trivedi, N. (2021). Disease-drug and drug-drug interaction in COVID-19: Risk and assessment. Biomedicine and Pharmacotherapy, 139, 111642.
National Health Commission Office. (2020). 'Civil Society' fights against COVID-19, meets both 'Thai and international', connecting hundreds of 'communities'. The National Health Commission Office. [Online URL: https://www.nationalhealth.or.th/en/node/2258] accessed on April 20, 2023.
Quispe-Cañari, J. F., Fidel-Rosales, E., Manrique, D., Mascaró-Zan, J., Huamán-Castillón, K. M., Chamorro-Espinoza, S. E., Garayar-Peceros, H., Ponce-López, V. L., Sifuentes-Rosales, J., Alvarez-Risco, A., Yáñez, J. A., and Mejia, C. R. (2021). Self-medication practices during the COVID-19 pandemic among the adult population in Peru: A cross-sectional survey. Saudi Pharmaceutical Journal, 29(1), 1–11.
Rajavithi Hospital. (n.d.). Pre-hospital risk assessment form for COVID-19 infection. [Online URL: https://covid19.rajavithi.go.th/test/th_index.php] accessed on April 20, 2023. [in Thai]
Rattanaraksa, D., Khempetch, R., Poolwiwatchaikool, U., Nimitvilai, S. Loatrakul, O., and Srimanee, P. (2021). The efficacy and safety of Andrographis paniculata extract for treatment of COVID-19 patients with mild symptoms, Nakhon Pathom Hospital. Medical Journal, 40(2), 269–282.
Saberian, P., Conovaloff, J. L., Vahidi, E., Hasani-Sharamin, P., and Kolivand, P. H. (2020). How the COVID-19 Epidemic Affected Prehospital Emergency Medical Services in Tehran, Iran. Western Journal of Emergency Medicine, 21(6), 110–116.
Sarai, K., and Onopas, S. (2022). Thai Sangha response to COVID 19: A case study of Wat Tanod, Bang Kruai district, Nonthaburi province, Thailand. International Journal of Buddhist Social Work, 1, 50–54.
Sarapat, P. (2020). Another step of the k-means algorithm that can classify all types of data. Big Data Institute. [Online URL: https://bdi.or.th/big-data-101/k-means-algorithm-for-clustering-large-data-sets-with-categorical-values/] accessed on April 20, 2023. [in Thai]
Scutariu, A. L., Șuşu, Ș., Huidumac-Petrescu, C. E., and Gogonea, R. M. (2022). A cluster analysis concerning the behavior of enterprises with e-commerce activity in the context of the COVID-19 pandemic. Journal of Theoretical and Applied Electronic Commerce Research, 17(1), 47–68.
Seol, H. (2022). Jamovi module: Cluster analysis. snowCluster. [Online URL: https://github.com/hyunsooseol/snowCluster] accessed on April 20, 2023.
Shafique, S., Faraz, N., and Wasti, H. (2021). Frequency of different symptoms in patients with COVID-19. The Professional Medical Journal, 28(07), 931–935.
Shi, J., Mo, X., and Sun, Z. (2012). Content validity index in scale development. Journal of Central South University, 37(2), 152–155.
Siripongboonsitti, T., Ungtrakul, T., Tawinprai, K., Auewarakul, C., Chartisathian, W., Jansala, T., Julsawad, R., Soonklang, K., Mahanonda, N., and Mahidol, C. (2023). Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial). Phytomedicine, 119, 155018.
Smith, P. K., Lesslar, O., and Price, D. B. (2022). Correspondence to "Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus". Allergy, 77(8), 2571–2573.
Srichampa, S., and Lochan, A. (2022). Care, share and adaptation of the Thai multicultural society during the global COVID-19 pandemic crisis. International Journal of Management and Social Sciences, 12(1), 17–26.
Struyf, T., Deeks, J. J., Dinnes, J., Takwoingi, Y., Davenport, C., Leeflang, M. M., Spijker, R., Hooft, L., Emperador, D., Dittrich, S., Domen, J., Horn, S. R. A., Van den Bruel, A., and Cochrane COVID-19 Diagnostic Test Accuracy Group. (2020). Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease. The Cochrane Database of Systematic Reviews, 5, CD013665.
Sundhani, E., Lukitaningsih, E., Nurrochmad, A., and Nugroho, A. E. (2022). Potential pharmacokinetic and pharmacodynamic herb-drug interactions of Andrographis paniculata (Burm. f.) and andrographolide: A systematic review. Journal of Herbmed Pharmacology, 11(2), 154–165.
Sungsana, W., Nakaranurack, C., Weeraphon, B., Charoenwaiyachet, W., Chanprasert, S., Torvorapanit, P., Santimaleeworagun, W., and Putcharoen, O. (2023). Telepharmacy during home isolation: Drug-related problems and pharmaceutical care in COVID-19 patients receiving antiviral therapy in Thailand. Journal of Pharmaceutical Policy and Practice, 16, 29.
The Government Public Relations Department. (2022). Wat Khiriwong (Wat Nam Tok), Chumphon province, delivers herbal medicine, Wat Khiriwong's recipe, to strengthen the immune system to fight COVID-19 to Surin province. [Online URL: https://www.prd.go.th/th/content/category/detail/id/9/iid/86417?fbclid=IwAR0OLotqGlytoTMw-aFHkivpBHqDWOE23xHdvORgawhp 4FNwRJBViSJA97k] accessed on October 2, 2023. [in Thai]
The Lancet Regional Health-Western Pacific. (2023). Where are the drugs? The scarcity of medications in the Western Pacific. The Lancet Regional Health-Western Pacific, 31, 100728.
The Nation Thailand. (2020). Trials underway to test efficacy of Andrographis paniculata extract for Covid-19. The Nation. [Online URL: https://www.nationthailand.com/news/30393547] accessed on October 2, 2023.
The Nation Thailand. (2023). Thai version of anti-COVID Molnupiravir to be made available this week. The Nation. [Online URL: https://www.nationthailand.com/thailand/general/40023558?fbclid=IwAR0M9ah0lq_3oXfIH2vw10ZkWtop1-Y4mtwOtJrOQDkVKcoco7gMuFoed-8] accessed on October 2, 2023.
Tuesuwan, B., Mueannoom, W., Jamnongtanachot, P., Khunvichai, A., Pavitrapok, C., Wongpakdee, K., Sra-Ium, S., Mahanonda, N., and Vongsutilers, V. (2023). Basis to aid crisis: Favipiravir oral solution for hospital compounding during COVID-19 drug shortage. Journal of Pharmaceutical Sciences, 112(2), 610–617.
Ullah, S., Mohd Nor, N. H., Daud, H., Zainuddin, N., Gandapur, M. S. J., Ali, I., and Khalil, A. (2021). Spatial cluster analysis of COVID-19 in Malaysia (Mar-Sep, 2020). Geospatial Health, 16(1), 137–144.
WHO. (2023). What are the symptoms of COVID-19? [Online URL: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19] accessed on April 20, 2023.
Yang, S. Q., Fang, Z. G., Lv, C. X., An, S. Y., Guan, P., Huang, D. S., and Wu, W. (2022). Spatiotemporal cluster analysis of COVID-19 and its relationship with environmental factors at the city level in mainland China. Environmental Science and Pollution Research International, 29, 13386–13395.
Ye, L., Fan, S., Zhao, P., Wu, C., Liu, M., Hu, S., Wang, P., Wang, H., and Bi, H. (2023). Potential herb‒drug interactions between anti-COVID-19 drugs and traditional Chinese medicine. Acta Pharmaceutica Sinica. B, 13(9), 3598–3637.
Zheng, Y., Liu, J., Tang, P. K., Hu, H., and Ung, C. O. L. (2023). A systematic review of self-medication practice during the COVID-19 pandemic: Implications for pharmacy practice in supporting public health measures. Frontiers in Public Health, 11, 1184882.